158 related articles for article (PubMed ID: 11041825)
1. [Causative immunopathologic mechanisms in pediatric urticaria following primary injection with anti-hepatitis B vaccine].
Barbaud A; Reichert-Pénétrat S; Béné MC; Kolopp-Sarda MN; Faure G; Kohler C; Schmutz JL
Ann Dermatol Venereol; 2000; 127(6-7):662-3. PubMed ID: 11041825
[No Abstract] [Full Text] [Related]
2. Responsiveness to intradermal recombinant hepatitis B vaccine.
CDR (Lond Engl Wkly); 1991 Oct; 1(43):198. PubMed ID: 1669886
[No Abstract] [Full Text] [Related]
3. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
[TBL] [Abstract][Full Text] [Related]
6. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
7. [Acute myelitis after immunization against hepatitis B with recombinant vaccine].
Senejoux A; Roulot D; Belin C; Tsakiris L; Rautureau J; Coste T
Gastroenterol Clin Biol; 1996; 20(4):401-2. PubMed ID: 8758508
[No Abstract] [Full Text] [Related]
8. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
9. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
Rao MN; Joshi N; Habibullah CM
Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
[No Abstract] [Full Text] [Related]
11. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
12. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults.
Rebedea I; Diaconescu IG; Bach D; Bartelsen O; Arndtz N
Vaccine; 2006 Jun; 24(25):5320-6. PubMed ID: 16707195
[TBL] [Abstract][Full Text] [Related]
13. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B vaccine: extending immunogenicity.
Horton RC
Br J Hosp Med; 1990 Jun; 43(6):409. PubMed ID: 2364233
[No Abstract] [Full Text] [Related]
15. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
16. IgE-mediated large local reaction from recombinant hepatitis B vaccine.
Ebo DG; Bridts CH; Stevens WJ
Allergy; 2008 Apr; 63(4):483-4. PubMed ID: 18315740
[No Abstract] [Full Text] [Related]
17. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
18. Response to hepatitis B vaccination in high risk population.
Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
[TBL] [Abstract][Full Text] [Related]
19. The effect of concurrent use of hepatitis B and Bacille Calmette-Guérin vaccination on anti-hepatitis B response.
Artan R; Erol M; Velipasaoglu S; Yegin O
Saudi Med J; 2004 Dec; 25(12):1939-42. PubMed ID: 15711671
[TBL] [Abstract][Full Text] [Related]
20. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
Beran J
Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]